In recent years, owing to abuse of antibiotics, extensive use of antitumor drugs and immunosuppressive agents and other reasons, an increasing number of people suffered from fungal infection. In this situation, researchers proposed new diagnosis methods, such as G test, galactomannan (GM) test, and polymerase chain reaction (PCR). G test is simple, quick, and highly sensitive and can detect multiple fungi; however, it cannot distinguish fungal types and may result in false positive and false negative results. GM test is less time consuming and feature highly positive detection rates but can simply be used in inspection of invasive aspergillosis. However, optimal positive critical values of GM test remain controversial. PCR is currently one of the fastest methods but is not formally used in clinical practice because of its lack of standardized operation and evaluation criteria. This study reviews the above three methods with the aim of discovering and summarizing their advantages and disadvantages to facilitate research and development of new diagnosis methods.
4 Yasemin Oz, Nuri Kiraz. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. 2011, 9(3):289-98.
5 Sarika Jain, Shukla Das, Neelima Gupta, et al. Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India. Medical Mycology. 2013, 51(2):164-9.
6 Jaijakul S, Vazquez JA, Swanson RN, et al. (1,3)-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis. Clinical Infectious Diseases. 2012, 55(4):521-6.
7 Lu Y, Chen YQ, Guo YL. Diagnosis of Invasive Fungal Disease Using Serum (1,3)-beta-D-Glucan: A Bivariate Meta-Analysis. Journal of Internal Medicine. 2011, 50(22):2783-91.
8 Lamoth F, Cruciani M, Mengoli C, et al. B-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3). Clinical Infectious Diseases. 2012, (5):633-43.
9 Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clinical Microbiology and Infection. 2013, 19 (1):39-49.
10 Mortensen KL, Johansen HK, Fuursted K, et al. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. European Journal. 2011, 30(11):1355-63.
11 Kobayashi K, Kimura S, Heux L, et al. Crystal transition between hydrate and anhydrous (1→3)-β-d-xylan from Penicillus dumetosus. Carbohydrate Polymers, 2013, 97 (1):105-110.
12 Albert O, Toubas D, Strady C, et al. Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis, 2011, 30 (11):1453-60.
13 Acosta J, Catalan M, Palacio-Pérez-Medel A, et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. Eur J Clin Microbiol Infect Dis, 2012, 31(5): 721-31.
14 Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clinical Microbiology Reviews. 2014, 27(3):490-526.
15 Luong ML, Filion C, Labbé AC, et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagnostic Microbiology & Infectious Disease. 2010, 68(2):132-9.
16 Mikulsks M, Furfaro Em Del Bono V, et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diagnostic Microbiology & Infectious Disease. 2012, 72(4):367-9.
17 Zhou X. Diagnosis value of serum galactomannan for detecting invasive pulmonary aspergillosis in patients with chronic. obstructive pulmonary disease. Clinical Education of General Practice, 2014,12(4):380-2.
18 Xafranski H, Melo AS, Machado AM, et al. A quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles. BMC Infectious Diseases. 2013, http://dx.doi.org/10.1186/1471-2334-13-467.
19 Luis Ostrosky-Zeichner. Invasive Mycoses: Diagnostic Challenges. The American Journal of Medicine. 2012, 125(1Suppl): S14-24.
20 Boondireke S, Mungthin M, Tanariya P, et al. Evaluation of sensitivity of multiplex PCR for Detection of Mycobacterium tuberculosis and Pneumocystis jirovecii in clinical samples. Journal of Clinical Microbiology. 2010, 48(9): 3165-8.
21 Xu F, He D, Sun X, et al. Establish a real-time PCR method to rapid identify Candida albicans. Chinese Journal of Laboratory Diagnosis, 2015, 19(4):528-31.
22 Zhao Y, Fu Y, Yin Z. The clinical value of assay of (1,3)-β-D-glucan in bronchoalveolar lavage fluid for invasive pulmonary fungal infection. Chinese journal of pathogen biology, 2015, 10(9):841-4.
23 Li S, Huang Y, Xu Y, et al. Detection of plasma (1-3)-β-D dextran in the diagnosis of deep fungal infection in patients with chemotherapy. Chinese journal of pathogen biology, 2011, 6(3):173-5,178.
24 Carlotta Francesca Orsi, Clotilde Bettua, Pietro Pini, et al. Detection of Pneumocystis jirovecii and Aspergillus spp. DNA in bronchoalveolar lavage fluids by commercial diagnostic tests. New Microbiologica. 2015, 38(1): 75-84.
25 White P L, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. Journal of Clinical Microbiology. 2010, 48(4):1231-40.
26 Rickerts V, Khot PD, Myerson Da, et al. Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infectious Diseases. 2011(11):201-13.
27 Babouee FB, Weisser M, Prince SS, et al. Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?. BMC Infectious Diseases. 2014(14):692.
28 Buitrago MJ, Bernal-Martinez L, Castelli MV, et al. Performance of panfungal and specific-PCR-based procedures for etiological diagnosis of invasive fungal diseases on tissue biopsy specimens with proven infection: a 7-year retrospective analysis from a reference laboratory. Journal of Clinical Microbiology. 2014, 52(5): 1737-40.
29 Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. L. Bernal-Martínez, M. J. Buitrago, M. V. Castelli, et al. Clinical Microbiology and Infection. 2013, 19(1): E1-7.
30 Gago S, Esteban C, Valero C, et al. A multiplex real-time PCR for the identification of Pneumocystis jirovecii, Histoplasma capsulatum and Cryptococcus neoformans/gattii causing opportunistic pneumonia in AIDS patients. J Clin Microbiol. 2014, 52(4): 1168-76.
31 Liu Z, Shao Y, Yang Y, et al. Establishment and clinical application of fungal quadruple PCR system. Chinese Journal of Dermatology and Venereology, 2015, 29(5):539-43.
32 Qishui O, Ling J, Ni L, et al. Comparison of real-time florescence quantitative PCR measurements of VAD1 mRNA with three conventional methods in diagnosis and follow-up treatment of Cryptococcus neoformans infection. Mycoses. 2012, 55(4):326-32.
33 Antinori S. New insights into HIV/AIDS-associated cryptococcosis. ISRN AIDS, 2013(12):471363.
34 Gago S, Esteban C, Valero C, et al. A multiplex real-time PCR for the identification of Pneumocystis jirovecii, Histoplasma capsulatum and Cryptococcus neoformans/gattii causing opportunistic pneumonia in AIDS patients. J Clin Microbiol. 2014, 52(4):1168-76.
35 Li Y, Hu Z. Application of molecular biology techniques in diagnosis and treatment of invasive fungal infection. Chinese Journal of Mycology, 2014, 9(6):377-80.
36 Wang B, Wei M, Fang H, et al. New Advances in Drug Resistance Mechanism of Candida. Chinese journal of pathogen biology, 2014, 9(5):473-7.